Impact of a Structured Brain Care Bundle on Severe Germinal Matrix Hemorrhage-Intraventricular Hemorrhage in Very

Asma Almazrooei1, Yasser Balubaid1, Nisreen Alkafi1

  • 1Neonatology Division, Pediatric Department, King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia.

Pediatric Neurology
|March 19, 2026
PubMed

Insights

Brain Care Bundles (BCBs) significantly reduced severe germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH) and late-onset sepsis in very preterm infants. This quality improvement strategy enhanced care in a Middle Eastern neonatal intensive care unit.

Area of Science:

  • Neonatalogy
  • Pediatric Neurology
  • Public Health

Background:

  • Germinal matrix hemorrhage-intraventricular hemorrhage (GMH-IVH) is a major cause of neurodevelopmental issues in preterm infants.
  • Standardized Brain Care Bundles (BCBs) show promise in reducing GMH-IVH, but data from Middle Eastern NICUs are scarce.

Purpose of the Study:

  • To evaluate the effectiveness of implementing a ten-component BCB in a Middle Eastern Level III NICU.
  • To assess the impact of BCBs on severe GMH-IVH rates and other neonatal morbidities.

Main Methods:

  • Retrospective cohort study comparing infants before (n=80) and after (n=77) BCB implementation (≤30 weeks gestation or ≤1500g birth weight).
  • Key BCB components included antenatal steroids, magnesium sulfate, delayed cord clamping, and neuroprotective measures.
  • Primary outcome was severe GMH-IVH (Papile grade III-periventricular hemorrhagic infarction); secondary outcomes included sepsis, NEC, BPD, ROP, and mortality.

Main Results:

  • Severe GMH-IVH incidence decreased from 15% to 5% post-BCB implementation (P=0.045).
  • BCB implementation was independently associated with reduced severe GMH-IVH (aOR=0.52; P=0.048) and significantly decreased late-onset sepsis (P=0.002).
  • Improved adherence to antenatal steroids and delayed cord clamping were noted post-BCB.

Conclusions:

  • Implementing BCBs in a high-risk Middle Eastern NICU significantly reduced severe GMH-IVH and late-onset sepsis.
  • BCBs represent a valuable quality improvement strategy for improving outcomes in vulnerable preterm infants.
  • The study supports the adoption of BCBs to enhance neuroprotection and reduce morbidity in neonatal intensive care settings.
Abstract